134 related articles for article (PubMed ID: 37482239)
1. High-Fat Diet Has a Protective Sex-Dependent Effect on Aortic Aneurysm Severity in a Marfan Syndrome Mouse Model.
Lau C; Muthu ML; Siddiqui IF; Li L; Reinhardt DP
Can J Cardiol; 2023 Nov; 39(11):1553-1567. PubMed ID: 37482239
[TBL] [Abstract][Full Text] [Related]
2. Fibrillin-1-regulated miR-122 has a critical role in thoracic aortic aneurysm formation.
Zhang RM; Tiedemann K; Muthu ML; Dinesh NEH; Komarova S; Ramkhelawon B; Reinhardt DP
Cell Mol Life Sci; 2022 May; 79(6):314. PubMed ID: 35606547
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
Xiong W; Knispel RA; Dietz HC; Ramirez F; Baxter BT
J Vasc Surg; 2008 Jan; 47(1):166-72; discussion 172. PubMed ID: 18178469
[TBL] [Abstract][Full Text] [Related]
4. Male Marfan mice are predisposed to high-fat diet-induced obesity, diabetes, and fatty liver.
Tiedemann K; Muthu ML; Reinhardt DP; Komarova SV
Am J Physiol Cell Physiol; 2022 Aug; 323(2):C354-C366. PubMed ID: 35759435
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
[TBL] [Abstract][Full Text] [Related]
6. Nitro-oleic acid reduces thoracic aortic aneurysm progression in a mouse model of Marfan syndrome.
Nettersheim FS; Lemties J; Braumann S; Geißen S; Bokredenghel S; Nies R; Hof A; Winkels H; Freeman BA; Klinke A; Rudolph V; Baldus S; Mehrkens D; Mollenhauer M; Adam M
Cardiovasc Res; 2022 Jul; 118(9):2211-2225. PubMed ID: 34324651
[TBL] [Abstract][Full Text] [Related]
7. Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome.
Jespersen K; Li C; Batra R; Stephenson CA; Harding P; Sestak K; Foley RT; Greene H; Meisinger T; Cook JR; Baxter BT; Xiong W
J Immunol Res; 2022; 2022():7538649. PubMed ID: 35211631
[TBL] [Abstract][Full Text] [Related]
8. IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome.
Ju X; Ijaz T; Sun H; Lejeune W; Vargas G; Shilagard T; Recinos A; Milewicz DM; Brasier AR; Tilton RG
J Am Heart Assoc; 2014 Jan; 3(1):e000476. PubMed ID: 24449804
[TBL] [Abstract][Full Text] [Related]
9. Redox Dysregulation of Vascular Smooth Muscle Sirtuin-1 in Thoracic Aortic Aneurysm in Marfan Syndrome.
Budbazar E; Sulser Ponce De Leon S; Tsukahara Y; Liu H; Huangfu Y; Wang Y; Seabra PM; Yang X; Goodman JB; Wan X; Chitalia V; Han J; Seta F
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):e339-e357. PubMed ID: 37288573
[TBL] [Abstract][Full Text] [Related]
10. Lineage-Specific Induced Pluripotent Stem Cell-Derived Smooth Muscle Cell Modeling Predicts Integrin Alpha-V Antagonism Reduces Aortic Root Aneurysm Formation in Marfan Syndrome Mice.
Nakamura K; Dalal AR; Yokoyama N; Pedroza AJ; Kusadokoro S; Mitchel O; Gilles C; Masoudian B; Leipzig M; Casey KM; Hiesinger W; Uchida T; Fischbein MP
Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1134-1153. PubMed ID: 37078287
[TBL] [Abstract][Full Text] [Related]
11. Short-term rapamycin treatment increases life span and attenuates aortic aneurysm in a murine model of Marfan-Syndrome.
Zaradzki M; Mohr F; Lont S; Soethoff J; Remes A; Arif R; Müller OJ; Karck M; Hecker M; Wagner AH
Biochem Pharmacol; 2022 Nov; 205():115280. PubMed ID: 36198355
[TBL] [Abstract][Full Text] [Related]
12. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
[TBL] [Abstract][Full Text] [Related]
13. FN (Fibronectin)-Integrin α5 Signaling Promotes Thoracic Aortic Aneurysm in a Mouse Model of Marfan Syndrome.
Chen M; Cavinato C; Hansen J; Tanaka K; Ren P; Hassab A; Li DS; Youshao E; Tellides G; Iyengar R; Humphrey JD; Schwartz MA
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):e132-e150. PubMed ID: 36994727
[TBL] [Abstract][Full Text] [Related]
14. AAV-mediated AP-1 decoy oligonucleotide expression inhibits aortic elastolysis in a mouse model of Marfan syndrome.
Remes A; Arif R; Franz M; Jungmann A; Zaradzki M; Puehler T; Heckmann MB; Frey N; Karck M; Kallenbach K; Hecker M; Müller OJ; Wagner AH
Cardiovasc Res; 2021 Nov; 117(12):2459-2473. PubMed ID: 33471064
[TBL] [Abstract][Full Text] [Related]
15. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
[TBL] [Abstract][Full Text] [Related]
16. An integrative systems approach identifies novel candidates in Marfan syndrome-related pathophysiology.
Bhushan R; Altinbas L; Jäger M; Zaradzki M; Lehmann D; Timmermann B; Clayton NP; Zhu Y; Kallenbach K; Kararigas G; Robinson PN
J Cell Mol Med; 2019 Apr; 23(4):2526-2535. PubMed ID: 30677223
[TBL] [Abstract][Full Text] [Related]
17. miR-29b participates in early aneurysm development in Marfan syndrome.
Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
[TBL] [Abstract][Full Text] [Related]
18. Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome.
Franken R; Teixido-Tura G; Brion M; Forteza A; Rodriguez-Palomares J; Gutierrez L; Garcia Dorado D; Pals G; Mulder BJ; Evangelista A
Heart; 2017 Nov; 103(22):1795-1799. PubMed ID: 28468757
[TBL] [Abstract][Full Text] [Related]
19. Insights into elastic fiber fragmentation: Mechanisms and treatment of aortic aneurysm in Marfan syndrome.
Seeburun S; Wu S; Hemani D; Pham L; Ju D; Xie Y; Kata P; Li L
Vascul Pharmacol; 2023 Dec; 153():107215. PubMed ID: 37640090
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.
Nistala H; Lee-Arteaga S; Carta L; Cook JR; Smaldone S; Siciliano G; Rifkin AN; Dietz HC; Rifkin DB; Ramirez F
Hum Mol Genet; 2010 Dec; 19(24):4790-8. PubMed ID: 20871099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
